Persones / Equip Humà

F. Xavier Palomer Tarridas

Buscador de publicacions

Publicacions

  • Botteri G, Montori M, Gumà A, Pizarro J, Cedó L, Escolà-Gil JC, Li D, Barroso E, Palomer FX, Kohan AB and Vazquez M.

    VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.

    Diabetologia . 60(11): 2262-2273. Nº de cites: 29

    [doi:10.1007/s00125-017-4401-5]

  • Palomer FX, Barroso E, Zarei M, Botteri G and Vazquez M.

    PPAR beta/delta and lipid metabolism in the heart

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS . 1861(10): 1569-1578. Nº de cites: 39

    [doi:10.1016/j.bbalip.2016.01.019]

  • Garcia-Ramírez M, Hernández C, Palomer FX, Vazquez M and Simó R.

    Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-?B activity.

    ACTA DIABETOL . 53(1): 109-118. Nº de cites: 29

    [doi:10.1007/s00592-015-0759-3]

  • Palomer FX, Capdevila-Busquets E, Botteri G, Davidson MM, Rodríguez C, Martínez-González J, Vidal F, Barroso E, Chan TO, Feldman AM and Vazquez M.

    miR-146a targets Fos expression in human cardiac cells

    DISEASE MODELS & MECHANISMS . 8(9): 1081-1091. Nº de cites: 37

    [doi:10.1242/dmm.020768]

  • Salvadó L, Palomer FX, Barroso E and Vazquez M.

    Targeting endoplasmic reticulum stress in insulin resistance.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 26(8): 438-448. Nº de cites: 169

    [doi:10.1016/j.tem.2015.05.007]

  • Barroso E, Rodríguez-Rodríguez R, Chacón MR, Maymó-Masip E, Ferrer L, Salvadó L, Salmerón E, Wabistch M, Palomer FX, Vendrell J, Wahli W and Vazquez M.

    PPARß/d ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1852(5): 1049-1058. Nº de cites: 18

    [doi:10.1016/j.bbadis.2015.02.010]

  • Chehaibi K, Cedó L, Metso J, Palomer FX, Santos D, Quesada H, Naceur Slimane M, Wahli W, Julve J, Vazquez M, Jauhiainen M, Blanco-Vaca F and Escolà-Gil JC.

    PPAR-ß/d activation promotes phospholipid transfer protein expression.

    BIOCHEMICAL PHARMACOLOGY . 94(2): 101-108. Nº de cites: 23

    [doi:10.1016/j.bcp.2015.01.016]

  • Masana L, Cabré A, Heras M, Amigó N, Correig X, Martínez-Hervás S, Real JT, Ascaso JF, Quesada H, Julve J, Palomer FX, Vazquez M, Girona J, Plana N and Blanco-Vaca F.

    Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.

    Atherosclerosis . 238(2): 213-219. Nº de cites: 20

    [doi:10.1016/j.atherosclerosis.2014.12.006]

  • Palomer FX, Capdevila-Busquets E, Garreta G, Davidson MM and Vazquez M.

    PPARa atena el estrs del retculo endoplasmtico inducido por palmitato en clulas cardacas humanas por medio de la induccin de la actividad AMPK.

    Clinica e Investigacion en Arteriosclerosis . 26(6): 255-267.

    [doi:10.1016/j.arteri.2014.02.003]

  • Salvadó L, Barroso E, Gómez-Foix AM, Palomer FX, Michalik L, Wahli W and Vazquez M.

    PPARß/d prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.

    Diabetologia . 57(10): 2126-2135. Nº de cites: 82

    [doi:10.1007/s00125-014-3331-8]